Rigel Pharmaceuticals (RI2.F) Q4 2024 Earnings

7NovConfirmed
Q2 2024
Q3 2024
Q4 2024
-0.47
-0.09
0.28
0.65

Details

Expected EPS
0.05413766556
Actual EPS
0.648067
Surprise EPS
0.59
Surprise Percent
+1,097.07%

Description

Rigel Pharmaceuticals (RI2.F) has reported earnings of 0.648067 per share for Q4 2024.

0 Comments

Share your thoughts